Literature DB >> 11994410

Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage.

Hiroki Mizukami1, Yide Mi, Ryuichi Wada, Mari Kono, Tadashi Yamashita, Yujing Liu, Norbert Werth, Roger Sandhoff, Konrad Sandhoff, Richard L Proia.   

Abstract

Gaucher disease, the most common lysosomal storage disease, is caused by a deficiency of glucocerebrosidase resulting in the impairment of glucosylceramide degradation. The hallmark of the disease is the presence of the Gaucher cell, a macrophage containing much of the stored glucosylceramide found in tissues, which is believed to cause many of the clinical manifestations of the disease. We have developed adult mice carrying the Gaucher disease L444P point mutation in the glucocerebrosidase (Gba) gene and exhibiting a partial enzyme deficiency. The mutant mice demonstrate multisystem inflammation, including evidence of B cell hyperproliferation, an aspect of the disease found in some patients. However, the mutant mice do not accumulate large amounts of glucosylceramide or exhibit classic Gaucher cells in tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994410      PMCID: PMC150961          DOI: 10.1172/JCI14530

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

Review 1.  Systemic AL amyloidosis in Gaucher disease. A case report and review of the literature.

Authors:  A Kaloterakis; A Filiotou; J Koskinas; I Raptis; C Zouboulis; H Michelakakis; S Hadziyannis
Journal:  J Intern Med       Date:  1999-12       Impact factor: 8.989

2.  Novel oral treatment of Gaucher's disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis.

Authors:  T Cox; R Lachmann; C Hollak; J Aerts; S van Weely; M Hrebícek; F Platt; T Butters; R Dwek; C Moyses; I Gow; D Elstein; A Zimran
Journal:  Lancet       Date:  2000-04-29       Impact factor: 79.321

3.  Consequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher disease.

Authors:  W M Holleran; E I Ginns; G K Menon; J U Grundmann; M Fartasch; C E McKinney; P M Elias; E Sidransky
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

4.  Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation.

Authors:  R Wada; C J Tifft; R L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

5.  Pathologic gene expression in Gaucher disease: up-regulation of cysteine proteinases including osteoclastic cathepsin K.

Authors:  M T Moran; J P Schofield; A R Hayman; G P Shi; E Young; T M Cox
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

6.  Gaucher's disease: a disease with chronic stimulation of the immune system.

Authors:  Y Shoenfeld; L A Gallant; M Shaklai; E Livni; M Djaldetti; J Pinkhas
Journal:  Arch Pathol Lab Med       Date:  1982-08       Impact factor: 5.534

7.  Reduced plasma concentrations of total, low density lipoprotein and high density lipoprotein cholesterol in patients with Gaucher type I disease.

Authors:  H Ginsberg; G A Grabowski; J C Gibson; R Fagerstrom; J Goldblatt; H S Gilbert; R J Desnick
Journal:  Clin Genet       Date:  1984-08       Impact factor: 4.438

8.  Association of Gaucher's disease and lymphoid malignancy in 2 children.

Authors:  Y Burstein; G Rechavi; A R Rausen; B Frisch; Z Spirer
Journal:  Scand J Haematol       Date:  1985-10

9.  Abnormalities in lipoprotein metabolism in Gaucher type 1 disease.

Authors:  N A Le; J C Gibson; A Rubinstein; G A Grabowski; H N Ginsberg
Journal:  Metabolism       Date:  1988-03       Impact factor: 8.694

10.  Multiple plasmocytomas of the liver and the spleen.

Authors:  D Garfinkel; F Salamon; Y Sidi; M Ben-Bassat; E Lubin; J Pinkhas
Journal:  Clin Nucl Med       Date:  1985-11       Impact factor: 7.794

View more
  55 in total

1.  Gaucher disease gene GBA functions in immune regulation.

Authors:  Jun Liu; Stephanie Halene; Mei Yang; Jameel Iqbal; Ruhua Yang; Wajahat Z Mehal; Wei-Lien Chuang; Dhanpat Jain; Tony Yuen; Li Sun; Mone Zaidi; Pramod K Mistry
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  Glycosphingolipid storage leads to the enhanced degradation of the B cell receptor in Sandhoff disease mice.

Authors:  Danielle te Vruchte; Aruna Jeans; Frances M Platt; Daniel John Sillence
Journal:  J Inherit Metab Dis       Date:  2010-05-11       Impact factor: 4.982

3.  Expanding spectrum of the association between Type 1 Gaucher disease and cancers: a series of patients with up to 3 sequential cancers of multiple types--correlation with genotype and phenotype.

Authors:  Sarah M Lo; Philip Stein; Sean Mullaly; Michael Bar; Dhanpat Jain; Gregory M Pastores; Pramod K Mistry
Journal:  Am J Hematol       Date:  2010-05       Impact factor: 10.047

Review 4.  Potential of animal models for advancing the understanding and treatment of pain in Parkinson's disease.

Authors:  Yazead Buhidma; Katarina Rukavina; Kallol Ray Chaudhuri; Susan Duty
Journal:  NPJ Parkinsons Dis       Date:  2020-01-06

5.  Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation.

Authors:  Shiny Nair; Chandra Sekhar Boddupalli; Rakesh Verma; Jun Liu; Ruhua Yang; Gregory M Pastores; Pramod K Mistry; Madhav V Dhodapkar
Journal:  Blood       Date:  2014-12-11       Impact factor: 22.113

Review 6.  Animal models for metabolic, neuromuscular and ophthalmological rare diseases.

Authors:  Guillaume Vaquer; Frida Rivière; Maria Mavris; Fabrizia Bignami; Jordi Llinares-Garcia; Kerstin Westermark; Bruno Sepodes
Journal:  Nat Rev Drug Discov       Date:  2013-03-15       Impact factor: 84.694

7.  Residual levels of tripeptidyl-peptidase I activity dramatically ameliorate disease in late-infantile neuronal ceroid lipofuscinosis.

Authors:  David E Sleat; Mukarram El-Banna; Istvan Sohar; Kwi-Hye Kim; Kostantin Dobrenis; Steven U Walkley; Peter Lobel
Journal:  Mol Genet Metab       Date:  2008-03-17       Impact factor: 4.797

8.  Upregulation of proinflammatory cytokines in the fetal brain of the Gaucher mouse.

Authors:  Young Bin Hong; Eun Young Kim; Sung-Chul Jung
Journal:  J Korean Med Sci       Date:  2006-08       Impact factor: 2.153

9.  Dysregulated sphingolipid metabolism in endometriosis.

Authors:  Yie Hou Lee; Chin Wen Tan; Abhishek Venkatratnam; Chuen Seng Tan; Liang Cui; Seong Feei Loh; Linda Griffith; Steven R Tannenbaum; Jerry Kok Yen Chan
Journal:  J Clin Endocrinol Metab       Date:  2014-06-24       Impact factor: 5.958

10.  Abnormal autophagy, ubiquitination, inflammation and apoptosis are dependent upon lysosomal storage and are useful biomarkers of mucopolysaccharidosis VI.

Authors:  Alessandra Tessitore; Marinella Pirozzi; Alberto Auricchio
Journal:  Pathogenetics       Date:  2009-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.